How many clinical trials are tracked for AL amyloidosis?

6 trials are tracked, 0 with published results.

Mode

All Oncology Infectious Disease Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Primary Care & Family Medicine Gastroenterology Nutrition & Obesity Medicine Orthopedics & Sports Medicine OB/GYN & Women's Health Radiology & Imaging Anesthesiology & Pain Medicine Genetics & Precision Medicine Pulmonology & Critical Care Physical Medicine & Rehab Nephrology Urology Emergency Medicine Ophthalmology Dermatology Hematology Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Questions

Text Size

AL amyloidosis

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for AL amyloidosis

6 trials tracked for AL amyloidosis.

6Trials tracked

0Phase 3 & 4

0Recruiting

0With published results

Phase distribution

Phase 2 6

Phase 2 A Phase I/II Trial of Pomalidomide and Dexamethasone in Subjects With Previously-Treated AL Amyloidosis Completed
Phase 2 The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis Completed
Phase 2 Bendamustine and Dexamethasone in Patients With Relapsed AL Amyloidosis Completed
Phase 2 COVID-19 VAX Booster Dosing in Patients With Hematologic Malignancies Completed
Phase 2 A Study to Evaluate the Safety and Tolerability of CAEL-101 in Patients With AL Amyloidosis Completed
Phase 2 Daratumumab for the Treatment of Patients With AL Amyloidosis Completed

Showing the 6 most-cited and recently-updated of 6 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.